Fluprednidene acetate

Pharmaceutical drug
  • D07AB07 (WHO) D07XB03 (WHO) (combinations)
Identifiers
  • 2-[(1R,2S,10S,11S,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,15-dimethyl-13-methylidene-5-oxotetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-14-yl]-2-oxoethyl acetate
CAS Number
  • 1255-35-2 checkY
PubChem CID
  • 9980241
DrugBank
  • DB08970 ☒N
ChemSpider
  • 8155833
UNII
  • GE65DV564S
KEGG
  • D07980
ChEBI
  • CHEBI:135700
CompTox Dashboard (EPA)
  • DTXSID0048719 Edit this at Wikidata
ECHA InfoCard100.013.649 Edit this at WikidataChemical and physical dataFormulaC24H29FO6Molar mass432.488 g·mol−13D model (JSmol)
  • Interactive image
  • CC(=O)OCC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)O
InChI
  • InChI=1S/C24H29FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,17-19,28,30H,1,5-6,9,11-12H2,2-4H3/t17-,18-,19-,21-,22-,23-,24-/m0/s1
  • Key:DEFOZIFYUBUHHU-IYQKUMFPSA-N
 ☒NcheckY (what is this?)  (verify)

Fluprednidene acetate (trade name Decoderm among others) is a moderately potent glucocorticoid used in form of a cream to treat skin inflammations such as atopic dermatitis and contact dermatitis.[1][2]

Contraindications

Similar to other corticoids, fluprednidene acetate is contraindicated in skin conditions that are caused by bacteria, fungi or viruses, including acne, syphilis, tuberculosis, as well as in rosacea and in children under two years of age. Insufficient data are available to judge safety during pregnancy and lactation.[1]

Side effects

Side effects are rare and include typical corticoid reactions such as skin atrophy, telangiectasias, stretch marks, and steroid acne. They mostly occur when large skin areas (more than 10% of body surface) are treated, when treatment is continued over more than two to four weeks, under occlusive therapy or therapy in skin folds. Hypersensitivity reactions have also been described.[1]

Pharmacology

Under open treatment, little substance reaches the circulation, and the body's own blood corticoid (cortisol) levels are not influenced. Under occlusive therapy, cortisol levels can be decreased because of a feedback reaction via the hypothalamic–pituitary–adrenal axis. This reaction is however not clinically significant.[1]

References

  1. ^ a b c d Haberfeld H, ed. (2017). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. Decoderm-Creme.
  2. ^ de Groot AC (February 2021). "Fluprednidene acetate". Monographs in Contact Allergy, Volume 3: Topical Drugs (First ed.). Boca Raton, FL: CRC Press. p. 355. ISBN 978-1-00-036786-7.

External links


  • v
  • t
  • e
Glucocorticoids
Natural
Synthetic
AntiglucocorticoidsSynthesis modifiers
See also
Glucocorticoid receptor modulators
Mineralocorticoids and antimineralocorticoids
List of corticosteroids
  • v
  • t
  • e
GRTooltip Glucocorticoid receptor
Agonists
  • Nonsteroidal glucocorticoids: AZD-5423
  • GSK-9027
Mixed
(SEGRMsTooltip Selective glucocorticoid receptor agonists)
Antagonists
Others
  • Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)
See also
Receptor/signaling modulators
Glucocorticoids and antiglucocorticoids
Mineralocorticoid receptor modulators
List of corticosteroids